MedPath

Oral vitamin E in reducing mucocutaneous side effects of Isotretinoi

Not Applicable
Conditions
acne vulgaris.
Acne vulgaris
Registration Number
IRCT138905022085N4
Lead Sponsor
Shahrekord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

suffering from Acne vulgaris, indication of treatment with Isotretinoin
Exclusion criteria: age lesser than 15 years old, pregnancy, breast feeding

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mucocutaneous side effects of Isotretinoin. Timepoint: After 4 and 6 weeks. Method of measurement: observation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath